CDH1 and cancer: In a previous study [6], we have demonstrated that AuNPs can be easily conjugated with the antibodies anti-β-catenin and anti-E-cadherin to specifically target colorectal carcinoma cells, whose clinical value can be found in an early diagnosis of cancer through non-invasive methods in body fluids such as saliva and urine.